Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

1.620

+0.020 (1.25%)

At close: Aug 26, 2025, 4:00 PM

1.620

0.00 (-0.01%)

After-hours: Aug 26, 2025, 7:15 PM EDT

Protalix BioTherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	61.95	53.4	65.49	47.64	38.35	62.9	Upgrade
Revenue Growth (YoY)	62.79%	-18.47%	37.48%	24.22%	-39.03%	15.00%	Upgrade
Cost of Revenue	26.31	24.32	22.98	19.59	16.35	10.87	Upgrade
Gross Profit	35.64	29.08	42.51	28.05	22	52.03	Upgrade
Selling, General & Admin	10.82	12.19	14.96	11.71	12.73	11.15	Upgrade
Research & Development	16.59	12.97	17.09	29.35	29.73	38.17	Upgrade
Operating Expenses	27.41	25.16	32.05	41.06	42.46	49.32	Upgrade
Operating Income	8.23	3.92	10.46	-13.01	-20.46	2.71	Upgrade
Interest Expense	-0.93	-1.06	-3.18	-2.53	-7.52	-9.67	Upgrade
Interest & Investment Income	0.79	1.3	1.29	1.15	0.4	0.44	Upgrade
EBT Excluding Unusual Items	8.09	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Pretax Income	8.09	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Income Tax Expense	1.81	1.22	0.25	0.53	-	-	Upgrade
Earnings From Continuing Operations	6.28	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income	6.28	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income to Common	6.28	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income Growth	-	-64.73%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	75	73	68	48	44	29	Upgrade
Shares Outstanding (Diluted)	83	81	82	48	44	29	Upgrade
Shares Change (YoY)	14.25%	-1.66%	70.04%	9.81%	51.43%	96.44%	Upgrade
EPS (Basic)	0.08	0.04	0.12	-0.31	-0.62	-0.22	Upgrade
EPS (Diluted)	0.08	0.04	0.09	-0.31	-0.62	-0.22	Upgrade
EPS Growth	-	-57.71%	-	-	-	-	Upgrade
Free Cash Flow	-3.44	7.39	-2.47	-25.63	-11.74	-26.76	Upgrade
Free Cash Flow Per Share	-0.04	0.09	-0.03	-0.53	-0.27	-0.92	Upgrade
Gross Margin	57.53%	54.46%	64.91%	58.87%	57.37%	82.71%	Upgrade
Operating Margin	13.28%	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Profit Margin	10.13%	5.49%	12.69%	-31.33%	-71.92%	-10.37%	Upgrade
Free Cash Flow Margin	-5.56%	13.84%	-3.77%	-53.80%	-30.62%	-42.55%	Upgrade
EBITDA	9.6	5.22	11.65	-11.93	-19.34	4.01	Upgrade
EBITDA Margin	15.49%	9.78%	17.79%	-25.04%	-50.44%	6.38%	Upgrade
D&A For EBITDA	1.37	1.3	1.19	1.09	1.12	1.3	Upgrade
EBIT	8.23	3.92	10.46	-13.01	-20.46	2.71	Upgrade
EBIT Margin	13.28%	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Effective Tax Rate	22.42%	29.42%	2.96%	-	-	-	Upgrade
Revenue as Reported	61.95	53.4	65.49	47.64	38.35	62.9	Upgrade

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q